Oasis Diagnostics

Oasis Diagnostics® Corporation was founded to conceive, develop, and commercialize high-quality tools for the non-invasive diagnosis and detection of diseases based on non-invasive specimens, particularly saliva or oral fluid. The Company’s technologies address the three main segments of the in vitro diagnostics [IVD] marketplace: molecular diagnostics [including DNA and, RNA], or nucleic acid testing [NAT], point of care [POC] testing and testing performed in the laboratory. At Oasis Diagnostics® Corporation, we believe the ability to use non-invasive and cost effective solutions for sample collection offers up multiple advantages over more invasive technologies that utilize blood, tissue, cerebrospinal fluid and others and has set about developing a portfolio of proprietary and patented devices with multiple applications in public health, testing for drugs of abuse, general wellness and others.